Novel Imaging Software Aids Diagnosis of Neurodegenerative Diseases
|
By MedImaging International staff writers Posted on 11 Feb 2020 |
|
Image: A software platform aids early detection of neurodegenerative diseases (Photo courtesy of Qynapse)
A new software platform quantifies magnetic resonance imaging (MRI) markers to support early diagnosis and clinical monitoring of central nervous system (CNS) degenerative disorders.
Qynapse (Paris, France) QyScore software is designed to provide automatic segmentation, labeling, visualization, and volumetric quantification of brain structures such as grey matter, white matter, hippocampus, amygdala, and white matter hyperintensities from a set of MRI scans. Outputs include an electronic report and color overlays of the segmentation on the input images, displayed in a dedicated graphical user interface (GUI) that allows the user to browse segmentations, compare the results to a reference healthy population, and read and edit a PDF report.
QyScore integrates with radiology information system (RIS) and picture archiving and communication system (PACS), and can be operated with MRI scans from 1.5T and 3T scanners for T1 MRI processing, and 3T scanners for T2-weighed fluid attenuated inversion recovery (FLAIR) processing. Quantification and brain segmentation are based on a probabilistic atlas and image intensity information, and volume calculations of the segmented brain structures, with the volumes normalized to allow for the statistical comparison with normative datasets.
“QyScore makes a difference for the diagnosis of dementias at an early stage of the disease when it remains a challenge,” said professor of neurology Bruno Dubois, MD, director of the Memory and Alzheimer's Disease Institute at Pitié Salpêtrière Hospital (Paris, France). “The automatic quantification of markers such as brain atrophy, white matter hyperintensities, and more, provides highly valuable help to support a timely diagnosis and an efficient monitoring of disease progression.”
Quantitative analysis of MRI data has become useful in both research and clinical studies, and crucial for the diagnosis and disease monitoring of patients with Multiple Sclerosis, Alzheimer’s disease, or vascular dementia. These pathologies are characterized by the presence of white matter or lesions, detectable on MRI scans as hyperintense areas on T2-weighed FLAIR images.
Related Links:
Qynapse
Pitié Salpêtrière Hospital
Qynapse (Paris, France) QyScore software is designed to provide automatic segmentation, labeling, visualization, and volumetric quantification of brain structures such as grey matter, white matter, hippocampus, amygdala, and white matter hyperintensities from a set of MRI scans. Outputs include an electronic report and color overlays of the segmentation on the input images, displayed in a dedicated graphical user interface (GUI) that allows the user to browse segmentations, compare the results to a reference healthy population, and read and edit a PDF report.
QyScore integrates with radiology information system (RIS) and picture archiving and communication system (PACS), and can be operated with MRI scans from 1.5T and 3T scanners for T1 MRI processing, and 3T scanners for T2-weighed fluid attenuated inversion recovery (FLAIR) processing. Quantification and brain segmentation are based on a probabilistic atlas and image intensity information, and volume calculations of the segmented brain structures, with the volumes normalized to allow for the statistical comparison with normative datasets.
“QyScore makes a difference for the diagnosis of dementias at an early stage of the disease when it remains a challenge,” said professor of neurology Bruno Dubois, MD, director of the Memory and Alzheimer's Disease Institute at Pitié Salpêtrière Hospital (Paris, France). “The automatic quantification of markers such as brain atrophy, white matter hyperintensities, and more, provides highly valuable help to support a timely diagnosis and an efficient monitoring of disease progression.”
Quantitative analysis of MRI data has become useful in both research and clinical studies, and crucial for the diagnosis and disease monitoring of patients with Multiple Sclerosis, Alzheimer’s disease, or vascular dementia. These pathologies are characterized by the presence of white matter or lesions, detectable on MRI scans as hyperintense areas on T2-weighed FLAIR images.
Related Links:
Qynapse
Pitié Salpêtrière Hospital
Adjustable Mobile Barrier
M-458
High-Precision QA Tool
DEXA Phantom
Ultrasound Needle Guidance System
SonoSite L25
Radiation Safety Barrier
RayShield Intensi-Barrier
Latest General/Advanced Imaging News
- AI Tool Offers Prognosis for Patients with Head and Neck Cancer
- New 3D Imaging System Addresses MRI, CT and Ultrasound Limitations
- AI-Based Tool Predicts Future Cardiovascular Events in Angina Patients
- AI-Based Tool Accelerates Detection of Kidney Cancer
- New Algorithm Dramatically Speeds Up Stroke Detection Scans
- 3D Scanning Approach Enables Ultra-Precise Brain Surgery
- AI Tool Improves Medical Imaging Process by 90%
- New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
- AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
- Cutting-Edge Angio-CT Solution Offers New Therapeutic Possibilities
- Extending CT Imaging Detects Hidden Blood Clots in Stroke Patients
- Groundbreaking AI Model Accurately Segments Liver Tumors from CT Scans
- New CT-Based Indicator Helps Predict Life-Threatening Postpartum Bleeding Cases
- CT Colonography Beats Stool DNA Testing for Colon Cancer Screening
- First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
- AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
Channels
Radiography
view channel
Routine Mammograms Could Predict Future Cardiovascular Disease in Women
Mammograms are widely used to screen for breast cancer, but they may also contain overlooked clues about cardiovascular health. Calcium deposits in the arteries of the breast signal stiffening blood vessels,... Read more
AI Detects Early Signs of Aging from Chest X-Rays
Chronological age does not always reflect how fast the body is truly aging, and current biological age tests often rely on DNA-based markers that may miss early organ-level decline. Detecting subtle, age-related... Read more
MRI
view channel
New Material Boosts MRI Image Quality
Magnetic resonance imaging (MRI) is a cornerstone of modern diagnostics, yet certain deep or anatomically complex tissues, including delicate structures of the eye and orbit, remain difficult to visualize clearly.... Read more
AI Model Reads and Diagnoses Brain MRI in Seconds
Brain MRI scans are critical for diagnosing strokes, hemorrhages, and other neurological disorders, but interpreting them can take hours or even days due to growing demand and limited specialist availability.... Read more
MRI Scan Breakthrough to Help Avoid Risky Invasive Tests for Heart Patients
Heart failure patients often require right heart catheterization to assess how severely their heart is struggling to pump blood, a procedure that involves inserting a tube into the heart to measure blood... Read more
MRI Scans Reveal Signature Patterns of Brain Activity to Predict Recovery from TBI
Recovery after traumatic brain injury (TBI) varies widely, with some patients regaining full function while others are left with lasting disabilities. Prognosis is especially difficult to assess in patients... Read moreUltrasound
view channel
Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
Ultrasound imaging depends on a conductive gel to eliminate air between the probe and the skin so sound waves can pass clearly into the body. While the imaging technology is fast, safe, and noninvasive,... Read more
AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery
Placenta accreta spectrum (PAS) is a life-threatening pregnancy complication in which the placenta abnormally attaches to the uterine wall. The condition is a leading cause of maternal mortality and morbidity... Read more
Nuclear Medicine
view channel
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
Targeted cancer therapies can be highly effective, but only when a patient’s tumor expresses the specific protein the treatment is designed to attack. Determining this usually requires biopsies or advanced... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more
